APA (7th ed.) Citation

FJ, H., P, P., E, K., M, H., K, J., A, U., . . . MK, D. (2019). Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 111(9), 887. https://doi.org/10.1093/jnci/djz081

Chicago Style (17th ed.) Citation

FJ, Hüttner, Probst P, Kalkum E, Hackbusch M, Jensen K, Ulrich A, Debus J, Jäger D, and Diener MK. "Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis." Journal of the National Cancer Institute 111, no. 9 (2019): 887. https://doi.org/10.1093/jnci/djz081.

MLA (9th ed.) Citation

FJ, Hüttner, et al. "Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis." Journal of the National Cancer Institute, vol. 111, no. 9, 2019, p. 887, https://doi.org/10.1093/jnci/djz081.